243 related articles for article (PubMed ID: 29968812)
1. Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets.
Wei H; Malcor JM; Harper MT
Sci Rep; 2018 Jul; 8(1):9987. PubMed ID: 29968812
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
Quinton TM; Kim S; Jin J; Kunapuli SP
J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles from activated platelets: a semiquantitative cryo-electron microscopy and immuno-gold labeling study.
Brisson AR; Tan S; Linares R; Gounou C; Arraud N
Platelets; 2017 May; 28(3):263-271. PubMed ID: 28102751
[TBL] [Abstract][Full Text] [Related]
5. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED: The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane.
Baglia FA; Shrimpton CN; López JA; Walsh PN
J Biol Chem; 2003 Jun; 278(24):21744-50. PubMed ID: 12517745
[TBL] [Abstract][Full Text] [Related]
7. 2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets.
Wei H; Davies JE; Harper MT
Cell Death Discov; 2020; 6():10. PubMed ID: 32140260
[TBL] [Abstract][Full Text] [Related]
8. ABT-737 Triggers Caspase-Dependent Inhibition of Platelet Procoagulant Extracellular Vesicle Release during Apoptosis and Secondary Necrosis In Vitro.
Wei H; Harper MT
Thromb Haemost; 2019 Oct; 119(10):1665-1674. PubMed ID: 31493778
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure.
Millington-Burgess SL; Harper MT
Sci Rep; 2021 Sep; 11(1):17678. PubMed ID: 34480042
[TBL] [Abstract][Full Text] [Related]
10. A critical role of lipid rafts in the organization of a key FcgammaRIIa-mediated signaling pathway in human platelets.
Bodin S; Viala C; Ragab A; Payrastre B
Thromb Haemost; 2003 Feb; 89(2):318-30. PubMed ID: 12574813
[TBL] [Abstract][Full Text] [Related]
11. Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin.
Tripisciano C; Weiss R; Eichhorn T; Spittler A; Heuser T; Fischer MB; Weber V
Sci Rep; 2017 Jul; 7(1):6522. PubMed ID: 28747771
[TBL] [Abstract][Full Text] [Related]
12. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
[TBL] [Abstract][Full Text] [Related]
13. The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses.
Moscardó A; Vallés J; Latorre A; Santos MT
FEBS Lett; 2014 Aug; 588(17):3154-9. PubMed ID: 24996187
[TBL] [Abstract][Full Text] [Related]
14. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant Effects of Low-Level Platelet Activation and Its Inhibition by Colchicine.
Reddel CJ; Pennings GJ; Curnow JL; Chen VM; Kritharides L
Thromb Haemost; 2018 Apr; 118(4):723-733. PubMed ID: 29554700
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets.
Yu Y; Gool E; Berckmans RJ; Coumans FAW; Barendrecht AD; Maas C; van der Wel NN; Altevogt P; Sturk A; Nieuwland R
J Thromb Haemost; 2018 Jun; 16(6):1153-1163. PubMed ID: 29658195
[TBL] [Abstract][Full Text] [Related]
17. Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187.
Ramström S; Rånby M; Lindahl TL
Thromb Haemost; 2003 Jan; 89(1):132-41. PubMed ID: 12540963
[TBL] [Abstract][Full Text] [Related]
18. Distinct localization of lipid rafts and externalized phosphatidylserine at the surface of apoptotic cells.
Ishii H; Mori T; Shiratsuchi A; Nakai Y; Shimada Y; Ohno-Iwashita Y; Nakanishi Y
Biochem Biophys Res Commun; 2005 Feb; 327(1):94-9. PubMed ID: 15629434
[TBL] [Abstract][Full Text] [Related]
19. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
Waheed AA; Shimada Y; Heijnen HF; Nakamura M; Inomata M; Hayashi M; Iwashita S; Slot JW; Ohno-Iwashita Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4926-31. PubMed ID: 11309501
[TBL] [Abstract][Full Text] [Related]
20. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.
Millington-Burgess SL; Harper MT
J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
